Q1 2023 Holdings
Filed 2023-05-15 | 74 holdings | $303.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Scilex Holding Co(SCLXUSD) | COM | 80880W106 | $3.8K | 463 | 0.0% |
| Rocket Pharmaceuticals Inc | *W EXP 09/02/202 | 77313F114 | $12.3K | 75,000 | 0.0% |
| Scilex Holding Co(SCLXW) | *W EXP 11/10/202 | 80880W114 | $19.0K | 18,099 | 0.0% |
| Newamsterdam Pharma Company | *W EXP 11/22/202 | N62509117 | $68.5K | 37,000 | 0.0% |
| Immatics N.v | *W EXP 07/01/202 | N44445117 | $269.6K | 187,204 | 0.1% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $299.6K | 306,950 | 0.1% |
| Glycomimetics Inc(GLYCEUR)Put | COM | 38000Q102 | $378.0K | 300,000 | 0.1% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $415.0K | 250,000 | 0.1% |
| NLS Pharmaceutics LTD | SHS | H57830103 | $519.6K | 344,089 | 0.2% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $548.0K | 177,349 | 0.2% |
| 89Bio Inc(ETNBGBP)Call | COM | 282559103 | $551.3K | 36,200 | 0.2% |
| Esperion Therapeutics Inc NE(ESPR)Put | COM | 29664W105 | $556.5K | 350,000 | 0.2% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $738.0K | 100,000 | 0.2% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $785.6K | 199,382 | 0.3% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $848.0K | 136,771 | 0.3% |
| Jasper Therapeutics Inc | COM | 471871103 | $863.3K | 476,948 | 0.3% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $871.0K | 325,000 | 0.3% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $872.2K | 98,221 | 0.3% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $978.8K | 62,500 | 0.3% |
| Aclaris Therapeutics Inc(ACRS)Call | COM | 00461U105 | $1.0M | 129,100 | 0.3% |
| Point Biopharma Global Inc | COM | 730541109 | $1.1M | 149,586 | 0.4% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $1.2M | 600,000 | 0.4% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $1.2M | 20,000 | 0.4% |
| Lianbio | SPONSORED ADR | 53000N108 | $1.3M | 650,000 | 0.4% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $1.3M | 150,000 | 0.4% |
| Precigen Inc | NOTE 3.500% 7/0 | 46122TAA0 | $1.5M | $1,500,000 | 0.5% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $1.5M | 143,064 | 0.5% |
| Vincerx Pharma Inc | COM NEW | 92731L106 | $1.6M | 1,492,771 | 0.5% |
| Viking Therapeutics Inc(VKTX)Put | COM | 92686J106 | $1.6M | 93,900 | 0.5% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $1.6M | 208,292 | 0.5% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $1.8M | 460,979 | 0.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $1.8M | 50,000 | 0.6% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $1.9M | 247,891 | 0.6% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $2.2M | 20,000 | 0.7% |
| Karuna Therapeutics Inc | COM | 48576A100 | $2.3M | 12,500 | 0.7% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $2.3M | 95,000 | 0.8% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $2.3M | 35,000 | 0.8% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $2.3M | 62,223 | 0.8% |
| Novavax Inc(NVAX)Put | COM NEW | 670002401 | $2.4M | 346,800 | 0.8% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $2.4M | 25,000 | 0.8% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $2.5M | 30,244 | 0.8% |
| Viridian Therapeutics Inc(VRDN)Call | COM | 92790C104 | $2.6M | 100,500 | 0.8% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADR | 152309100 | $2.6M | 684,127 | 0.9% |
| Esperion Therapeutics Inc NE | NOTE 4.000%11/1 | 29664WAB1 | $3.0M | $7,500,000 | 1.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $3.0M | 200,000 | 1.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $3.2M | 90,000 | 1.1% |
| Astrazeneca PLC(AZN)Call | SPONSORED ADR | 046353108 | $3.5M | 50,000 | 1.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $4.0M | 10,750 | 1.3% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $4.0M | 20,000 | 1.3% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $4.2M | 60,000 | 1.4% |